Drug tolerance
Showing 1 - 25 of >10,000
Healthy Trial in Seoul (Test Drug(JW0302) or Reference Drug(C2206))
Not yet recruiting
- Healthy
- Test Drug(JW0302) or Reference Drug(C2206)
-
Seoul, Korea, Republic ofClinical Trial Center, Seoul National University Hospital
Mar 14, 2023
Healthy Trial in Seoul (Reference Drug or Test Drug)
Recruiting
- Healthy
- Reference Drug or Test Drug
-
Seoul, Korea, Republic ofClinical Trial Center, Seoul National University Hospital
Jun 22, 2022
Healthy Trial in Jeonju (Treatment A, Treatment B, Treatment C)
Completed
- Healthy
- Treatment A
- +4 more
-
Jeonju, Jeollabuk-do, Korea, Republic ofJeonbuk National University Hospita
Jul 18, 2022
Pharmacokinetics Trial in Nanjing (Group 1:YK-1169, Group 2:YK-1169/Placebo Injection, Group 3:YK-1169/Placebo)
Completed
- Pharmacokinetics
- Group 1:YK-1169
- +5 more
-
Nanjing, Jiangsu, China辛玉霞
Oct 18, 2022
Hypertriglyceridemia, Familial Trial in Nanjing (GC304)
Not yet recruiting
- Hypertriglyceridemia, Familial
- GC304
-
Nanjing, ChinaAffiliated Jinling Hospital, Medical School, Nanjing University
May 5, 2023
Advanced Malignant Tumor Trial (HRS-2189 Tablets)
Not yet recruiting
- Advanced Malignant Tumor
- HRS-2189 Tablets
- (no location specified)
May 6, 2023
Cannabis Use Disorder Trial (Emotional Engagement Distress Tolerance Intervention, Health Education Intervention)
Not yet recruiting
- Cannabis Use Disorder
- Emotional Engagement Distress Tolerance Intervention
- Health Education Intervention
- (no location specified)
Oct 15, 2023
Substance Use Disorders Trial in Pittsburgh, Wilkinsburg (Distress Tolerance - Benzodiazepine Discontinuation (DT-BD),
Recruiting
- Substance Use Disorders
- Distress Tolerance - Benzodiazepine Discontinuation (DT-BD)
- Relaxation Therapy
-
Pittsburgh, Pennsylvania
- +2 more
Aug 2, 2022
Safety Issues, Effect of Drug, Tolerance Trial in Beijing (MB07133)
Recruiting
- Safety Issues
- +2 more
-
Beijing, Beijing, ChinaFifth Medical Center of Chinese PLA General Hospital
Nov 17, 2023
Normal Drug Tolerance Trial in Hartford (TP-434 (Eravacycline) reconstituted and administered via an IV infusion)
Completed
- Normal Drug Tolerance
- TP-434 (Eravacycline) reconstituted and administered via an IV infusion
-
Hartford, ConnecticutCenter for Anti-infective Research and Development; Hartford Hos
Dec 16, 2021
Cannabis, Pain, Tolerance Trial in New York (Cannabis)
Recruiting
- Cannabis
- +3 more
-
New York, New YorkNew York State Psychiatric Institute
Aug 29, 2022
Substance Use Disorders Trial in Boston (Distress Tolerance - Benzodiazepine Discontinuation (DT-BD), BZD discontinuation
Completed
- Substance Use Disorders
- Distress Tolerance - Benzodiazepine Discontinuation (DT-BD)
- BZD discontinuation protocol
-
Boston, MassachusettsBoston Medical Center
Jan 20, 2022
Chronic Pain Trial in Boston (Morphine, Guanfacine 1mg, Guanfacine 2mg)
Active, not recruiting
- Chronic Pain
- Morphine
- +3 more
-
Boston, MassachusettsCenter for Translational Pain Research
Apr 4, 2022
Treatment With Steroids and PEG- Asparaginase in Children and
Recruiting
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- +3 more
-
Aarhus N, DenmarkAarhus University Hospital
May 15, 2023
Liver Transplant Trial in Boston (biological, procedure, drug)
Recruiting
- Liver Transplant
- arTreg-CSB
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital: Transplantation
Jan 30, 2023
Glioblastoma Trial in Birmingham (Autologous genetically modified gamma-delta T cells, Allogeneic genetically modified
Not yet recruiting
- Glioblastoma
- Autologous genetically modified gamma-delta T cells
- Allogeneic genetically modified gamma-delta T cells
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Dec 16, 2022
Breast Cancer, Gastric Cancer, Gastroesophageal-junction Cancer Trial in Australia (IKS014)
Not yet recruiting
- Breast Cancer
- +2 more
-
Concord, New South Wales, Australia
- +4 more
May 30, 2023
Liver Transplant Trial in San Francisco (biological, procedure, drug)
Recruiting
- Liver Transplant
- arTreg
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 13, 2022
Advanced Malignant Solid Tumors Trial (Treatment of MNC-168 enteric-coated capsules as a single oral drug)
Not yet recruiting
- Advanced Malignant Solid Tumors
- Treatment of MNC-168 enteric-coated capsules as a single oral drug
- (no location specified)
May 31, 2022
Pre Diabetes Trial in Liverpool (Body Composition, Maximal aerobic fitness test, Oral glucose tolerance test)
Recruiting
- Pre Diabetes
- Body Composition
- +4 more
-
Liverpool, Merseyside, United KingdomLiverpool John Moores University
Sep 7, 2021
Hyperphosphatemia Trial in Changchun (Lanthanum Polystyrene Sulphonate Powder, Lanthanum Carbonate 500 MG, Placebo)
Recruiting
- Hyperphosphatemia
- Lanthanum Polystyrene Sulphonate Powder
- +2 more
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Jul 27, 2021
HIV, Pregnancy Trial in San Francisco, Boston, Bronx (Indinavir sulfate, Lamivudine, Zidovudine)
Completed
- HIV Infections
- Pregnancy
- Indinavir sulfate
- +2 more
-
San Francisco, California
- +3 more
Oct 27, 2021
Smoking Cessation, Weight Loss Trial in Providence (Distress Tolerance, transdermal nicotine patch, Active Health Control)
Suspended
- Smoking Cessation
- Weight Loss
- Distress Tolerance
- +2 more
-
Providence, Rhode IslandRhode Island College
Sep 15, 2021
Tobacco Smoking Trial in Boston (Distress Tolerance Intervention, Working Memory Intervention, Control Informational
Completed
- Tobacco Smoking
- Distress Tolerance Intervention
- +2 more
-
Boston, MassachusettsBoston University
Jul 21, 2021